High-intensity exercise and cognitive function in cognitively normal older adults: a pilot randomised clinical trial.


Journal

Alzheimer's research & therapy
ISSN: 1758-9193
Titre abrégé: Alzheimers Res Ther
Pays: England
ID NLM: 101511643

Informations de publication

Date de publication:
01 02 2021
Historique:
received: 18 09 2020
accepted: 15 01 2021
entrez: 1 2 2021
pubmed: 2 2 2021
medline: 25 6 2021
Statut: epublish

Résumé

Physical inactivity has been consistently linked to increased risk of cognitive decline; however, studies examining the impact of exercise interventions on cognition have produced inconsistent findings. Some observational studies suggest exercise intensity may be important for inducing cognitive improvements; however, this has yet to be thoroughly examined in older adult cohorts. The objective of the current study was to evaluate the effect of systematically manipulated high-intensity and moderate-intensity exercise interventions on cognition. This multi-arm pilot randomised clinical trial investigated the effects of 6 months of high-intensity exercise and moderate-intensity exercise, compared with an inactive control, on cognition. Outcome measures were assessed at pre- (baseline), post- (6 months), and 12 months post-intervention. Ninety-nine cognitively normal men and women (aged 60-80 years) were enrolled from October 2016 to November 2017. Participants that were allocated to an exercise group (i.e. high-intensity or moderate-intensity) engaged in cycle-based exercise two times per week for 6 months. Cognition was assessed using a comprehensive neuropsychological test battery. Cardiorespiratory fitness was evaluated by a graded exercise test. There was a dose-dependent effect of exercise intensity on cardiorespiratory fitness, whereby the high-intensity group experienced greater increases in fitness than the moderate-intensity and control groups. However, there was no direct effect of exercise on cognition. We did not observe a direct effect of exercise on cognition. Future work in this field should be appropriately designed and powered to examine factors that may contribute to individual variability in response to intervention. This study is registered with the Australian New Zealand Clinical Trials Registry (ACTRN12617000643370). Registered on 3 May 2017-retrospectively registered. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=372780.

Sections du résumé

BACKGROUND
Physical inactivity has been consistently linked to increased risk of cognitive decline; however, studies examining the impact of exercise interventions on cognition have produced inconsistent findings. Some observational studies suggest exercise intensity may be important for inducing cognitive improvements; however, this has yet to be thoroughly examined in older adult cohorts. The objective of the current study was to evaluate the effect of systematically manipulated high-intensity and moderate-intensity exercise interventions on cognition.
METHODS
This multi-arm pilot randomised clinical trial investigated the effects of 6 months of high-intensity exercise and moderate-intensity exercise, compared with an inactive control, on cognition. Outcome measures were assessed at pre- (baseline), post- (6 months), and 12 months post-intervention. Ninety-nine cognitively normal men and women (aged 60-80 years) were enrolled from October 2016 to November 2017. Participants that were allocated to an exercise group (i.e. high-intensity or moderate-intensity) engaged in cycle-based exercise two times per week for 6 months. Cognition was assessed using a comprehensive neuropsychological test battery. Cardiorespiratory fitness was evaluated by a graded exercise test.
RESULTS
There was a dose-dependent effect of exercise intensity on cardiorespiratory fitness, whereby the high-intensity group experienced greater increases in fitness than the moderate-intensity and control groups. However, there was no direct effect of exercise on cognition.
CONCLUSIONS
We did not observe a direct effect of exercise on cognition. Future work in this field should be appropriately designed and powered to examine factors that may contribute to individual variability in response to intervention.
TRIAL REGISTRATION
This study is registered with the Australian New Zealand Clinical Trials Registry (ACTRN12617000643370). Registered on 3 May 2017-retrospectively registered. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=372780.

Identifiants

pubmed: 33522961
doi: 10.1186/s13195-021-00774-y
pii: 10.1186/s13195-021-00774-y
pmc: PMC7849126
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

33

Subventions

Organisme : NIA NIH HHS
ID : P30 AG024827
Pays : United States

Références

Physiol Behav. 2016 Mar 1;155:224-30
pubmed: 26723268
Dement Geriatr Cogn Disord. 2007;23(1):29-34
pubmed: 17068394
Cochrane Database Syst Rev. 2015 Apr 22;(4):CD005381
pubmed: 25900537
Percept Mot Skills. 2014 Feb;118(1):63-72
pubmed: 24724513
Mol Psychiatry. 2013 Aug;18(8):875-81
pubmed: 22889922
Hum Brain Mapp. 2013 Nov;34(11):2972-85
pubmed: 22674729
Alzheimers Dement (N Y). 2017 Oct 19;3(4):562-570
pubmed: 29124115
J Sci Med Sport. 2017 Oct;20(10):899-903
pubmed: 28511848
Behav Brain Res. 2019 Apr 19;362:103-108
pubmed: 30639507
J Aging Phys Act. 2020 Apr 16;:1-10
pubmed: 32303000
Neurology. 2014 Oct 7;83(15):1345-52
pubmed: 25186863
Eur J Cardiovasc Prev Rehabil. 2007 Dec;14(6):825-30
pubmed: 18043306
Trials. 2010 Mar 24;11:32
pubmed: 20334632
Br J Sports Med. 2018 Feb;52(3):154-160
pubmed: 28438770
Lancet Neurol. 2014 Aug;13(8):788-94
pubmed: 25030513
J Alzheimers Dis. 2017;56(1):297-303
pubmed: 27911292
West J Nurs Res. 2020 Aug;42(8):660-673
pubmed: 32075548
J Int Neuropsychol Soc. 2015 Nov;21(10):757-67
pubmed: 26581788
PLoS One. 2015 Jul 09;10(7):e0131647
pubmed: 26158265
Transl Psychiatry. 2012 Nov 20;2:e191
pubmed: 23168991
Mol Psychiatry. 2015 Nov;20(11):1322-8
pubmed: 25288138
Appl Physiol Nutr Metab. 2020 Jun;45(6):591-600
pubmed: 31665610
Front Neurosci. 2018 Feb 07;12:52
pubmed: 29467613

Auteurs

Belinda M Brown (BM)

Discipline of Exercise Science, College of Science, Health, Engineering and Education, Murdoch University, 90 South Street, Murdoch, WA, 6150, Australia. b.brown@murdoch.edu.au.
Australian Alzheimer's Research Foundation, Sarich Neuroscience Research Institute, Nedlands, Western Australia, Australia. b.brown@murdoch.edu.au.
Centre for Healthy Ageing, Murdoch University, Murdoch, Western Australia, Australia. b.brown@murdoch.edu.au.
School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia. b.brown@murdoch.edu.au.

Natalie Frost (N)

School of Psychological Science, University of Western Australia, Crawley, Western Australia, Australia.

Stephanie R Rainey-Smith (SR)

Australian Alzheimer's Research Foundation, Sarich Neuroscience Research Institute, Nedlands, Western Australia, Australia.
Centre for Healthy Ageing, Murdoch University, Murdoch, Western Australia, Australia.
School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
School of Psychological Science, University of Western Australia, Crawley, Western Australia, Australia.

James Doecke (J)

Australian eHealth Research Centre, CSIRO, Brisbane, Queensland, Australia.
Department of Biomedical Sciences, Macquarie University, Sydney, New South Wales, Australia.

Shaun Markovic (S)

Discipline of Exercise Science, College of Science, Health, Engineering and Education, Murdoch University, 90 South Street, Murdoch, WA, 6150, Australia.
Australian Alzheimer's Research Foundation, Sarich Neuroscience Research Institute, Nedlands, Western Australia, Australia.

Nicole Gordon (N)

Discipline of Exercise Science, College of Science, Health, Engineering and Education, Murdoch University, 90 South Street, Murdoch, WA, 6150, Australia.

Michael Weinborn (M)

Australian Alzheimer's Research Foundation, Sarich Neuroscience Research Institute, Nedlands, Western Australia, Australia.
School of Psychological Science, University of Western Australia, Crawley, Western Australia, Australia.

Hamid R Sohrabi (HR)

Australian Alzheimer's Research Foundation, Sarich Neuroscience Research Institute, Nedlands, Western Australia, Australia.
Centre for Healthy Ageing, Murdoch University, Murdoch, Western Australia, Australia.
School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
Department of Biomedical Sciences, Macquarie University, Sydney, New South Wales, Australia.

Simon M Laws (SM)

School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
Collaborative Genomics and Translation Group, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
School of Pharmacy and Biomedical Sciences, Faculty of Health Sciences, Curtin Health Innovation Research Institute, Curtin University, Bentley, Western Australia, Australia.

Ralph N Martins (RN)

Australian Alzheimer's Research Foundation, Sarich Neuroscience Research Institute, Nedlands, Western Australia, Australia.
School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.
Department of Biomedical Sciences, Macquarie University, Sydney, New South Wales, Australia.

Kirk I Erickson (KI)

Discipline of Exercise Science, College of Science, Health, Engineering and Education, Murdoch University, 90 South Street, Murdoch, WA, 6150, Australia.
Department of Psychology, University of Pittsburgh, Pittsburgh, PA, USA.

Jeremiah J Peiffer (JJ)

Discipline of Exercise Science, College of Science, Health, Engineering and Education, Murdoch University, 90 South Street, Murdoch, WA, 6150, Australia.
Centre for Healthy Ageing, Murdoch University, Murdoch, Western Australia, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH